Source:http://linkedlifedata.com/resource/pubmed/id/10436256
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1-2
|
pubmed:dateCreated |
2000-4-5
|
pubmed:abstractText |
Thiamine plays an important role in the regulation of glucose metabolism and pancreatic beta-cell functioning. A role for this vitamin in cellular glucose transport has been indicated in the literature. The aim of this study was to determine whether a lipophilic form of thiamine (benzoyloxymethyl-thiamine, BOM) was able to improve metabolic control in patients with long-standing insulin-dependent diabetes mellitus (type 1). A total of 10 children with type 1 diabetes of long duration (age 11.4 +/- 1.2 years, duration of the disease 4.5 +/- 0.7 years, means +/- SEM) were studied before and after treatment with BOM in a randomized double-blind and placebo-controlled study. Five patients were assigned to the BOM-treated group and five to the placebo-group. In all patients basal and glucagon-stimulated C-peptide secretion was undetectable. Thiamine status was assayed by measuring the plasma content of thiamine and its monophosphate form at entry and after 3 months of treatment. The blood HbA(1C) levels and the daily dose of insulin per kg body weight were assessed in both groups before treatment, after 1 month and 3 months of treatment, then 3 months following its suspension. The plasma content of thiamine + thiamine monophosphate in type 1 diabetic patients (35.3 +/- 3.6 pmol/mL) was significantly lower when compared with that measured in six age-matched normal subjects (53.2 +/- 2.3 pmol/mL, P < 0.05).
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/C-Peptide,
http://linkedlifedata.com/resource/pubmed/chemical/Glucagon,
http://linkedlifedata.com/resource/pubmed/chemical/Hemoglobin A, Glycosylated,
http://linkedlifedata.com/resource/pubmed/chemical/Hypoglycemic Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Insulin,
http://linkedlifedata.com/resource/pubmed/chemical/Placebos,
http://linkedlifedata.com/resource/pubmed/chemical/Thiamine,
http://linkedlifedata.com/resource/pubmed/chemical/Thiamine Monophosphate,
http://linkedlifedata.com/resource/pubmed/chemical/bentiamine
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
0940-5429
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
36
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
73-6
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:10436256-Adolescent,
pubmed-meshheading:10436256-Age of Onset,
pubmed-meshheading:10436256-C-Peptide,
pubmed-meshheading:10436256-Child,
pubmed-meshheading:10436256-Child, Preschool,
pubmed-meshheading:10436256-Diabetes Mellitus, Type 1,
pubmed-meshheading:10436256-Double-Blind Method,
pubmed-meshheading:10436256-Glucagon,
pubmed-meshheading:10436256-Hemoglobin A, Glycosylated,
pubmed-meshheading:10436256-Humans,
pubmed-meshheading:10436256-Hypoglycemic Agents,
pubmed-meshheading:10436256-Insulin,
pubmed-meshheading:10436256-Placebos,
pubmed-meshheading:10436256-Reference Values,
pubmed-meshheading:10436256-Thiamine,
pubmed-meshheading:10436256-Thiamine Monophosphate,
pubmed-meshheading:10436256-Time Factors
|
pubmed:year |
1999
|
pubmed:articleTitle |
Lipophilic thiamine treatment in long-standing insulin-dependent diabetes mellitus.
|
pubmed:affiliation |
Department of Pediatrics, P.le S. Maria della Misericordia, I-33100 Udine, Italy.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial
|